ADC Therapeutics to Provide Initial Data Update on LOTIS-7 Clinical Trial

Company to host corporate update webcast to share results on December 11, 2024 LAUSANNE, Switzerland, Dec. 6, 2024 /PRNewswire/ — ADC Therapeutics SA (NYSE: ADCT), today announced that it will host a conference call and live webcast on Wednesday, December 11, 2024, at 8:30 a.m. EST to…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.